This trial collects medical information from patients with head and neck cancer that have received or are scheduled to receive proton therapy. Collecting and analyzing medical information from patients may provide information on the outcomes and treatment related side effects of proton therapy for head and neck cancer and help doctors improve therapy for future patients with head and neck cancer.
PRIMARY OBJECTIVE: I. To evaluate the outcomes in patients who have received treatment for their head and neck malignancy with proton radiation therapy. OUTLINE: Patients complete questionnaires over 30 minutes before treatment begins, at each visit during treatment, and again at all follow-up visits related to treatment. Patients also have their medical records reviewed.
Study Type
OBSERVATIONAL
Enrollment
450
Review of medical records
Complete questionnaires
M D Anderson Cancer Center
Houston, Texas, United States
Overall survival analysis of proton therapy for head and neck malignancies
Retrospective chart analysis will be performed on all patients documented to have head and neck cancer, treated with Proton Therapy at MDACC from January 1, 2008 through April 30, 2012. Prospective chart analysis will be performed on head and neck cancer patients currently being treated at MD Anderson Cancer Center beginning May 1, 2012 through December 31, 2018. Overall survival estimated using Kaplan-Meier method. Cox proportional hazards regression used to explore predictors of time-to-event outcomes. Mann-Whitney test used to compare continuous parameters between temporal cohorts.
Time frame: 7 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.